Bridging innate and adaptive antitumor immunity targeting glycans

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Pashov, Anastas ^a   Monzavi Karbassi, Bejatolah ^a   Raghava, Gajendra P S ^b   Kieber Emmons, Thomas ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLYCAN DERIVATIVE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUCIN 1; ANTINEOPLASTIC AGENT; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; GENE TARGETING; HUMAN; IMMUNE SYSTEM; IMMUNOREACTIVITY; IMMUNOTHERAPY; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE STRUCTURE; PROTEIN MODIFICATION; REVIEW; ANIMAL; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METHODOLOGY; MOUSE; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNITY, INNATE; MICE; T-LYMPHOCYTES;

EID: 77954549536     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/354068     Document Type: Review

References (193)

1. Chaudhuri D., Suriano R., Mittelman A., Tiwari R. K., Targeting the immune system in cancer Current Pharmaceutical Biotechnology 2009 10 2 166 184
2. Bhardwaj N., Harnessing the immune system to treat cancer Journal of Clinical Investigation 2007 117 5 1130 1136
3. Sun J. C., Lanier L. L., Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? European Journal of Immunology 2009 39 8 2059 2064
4. Raulet D. H., Interplay of natural killer cells and their receptors with the adaptive immune response Nature Immunology 2004 5 10 996 1002
5. Bui J. D., Schreiber R. D., Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Current Opinion in Immunology 2007 19 2 203 208
6. Zitvogel L., Tesniere A., Kroemer G., Cancer despite immunosurveillance: immunoselection and immunosubversion Nature Reviews Immunology 2006 6 10 715 727
7. Boon T., van Baren N., Immunosurveillance against cancer and immunotherapysynergy or antagonism? The New England Journal of Medicine 2003 348 3 252 254
8. Ochsenbein A. F., Klenerman P., Karrer U., Ludewig B., Pericin M., Hengartner H., Zinkernagel R. M., Immune surveillance against a solid tumor fails because of immunological ignorance Proceedings of the National Academy of Sciences of the United States of America 1999 96 5 2233 2238
9. Vollmers H. P., Brndlein S., Natural antibodies and cancer New Biotechnology 2009 25 5 294 298
10. Toubi E., Shoenfeld Y., Protective autoimmunity in cancer (review) Oncology Reports 2007 17 1 245 251
11. Dougan M., Dranoff G., Immune therapy for cancer Annual Review of Immunology 2009 27 83 117
12. Nishimura M. I., Roszkowski J. J., Moore T. V., Brasic N., McKee M. D., Clay T. M., Antigen recognition and T-cell biology Cancer Treatment and Research 2005 123 37 59
13. Boon T., Coulie P. G., van den Eynde B. J., van der Bruggen P., Human T cell responses against melanoma Annual Review of Immunology 2006 24 175 208
14. Disis M. L., Park K. H., Immunomodulation of breast cancer via tumor antigen specific Th1 Cancer Research and Treatment 2009 41 3 117 121
15. Dranoff G., Targets of protective tumor immunity Annals of the New York Academy of Sciences 2009 1174 74 80
16. Gray A., Raff A. B., Chiriva-Internati M., Chen S.-Y., Kast W. M., A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting Immunological Reviews 2008 222 1 316 327
17. Carmichael M. G., Benavides L. C., Holmes J. P., Gates J. D., Mittendorf E. A., Ponniah S., Peoples G. E., Results of the first phase 1 clinical trial of the HER-2/ neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04 Cancer 2010 116 2 292 301
18. Salazar L. G., Disis M. L., Cancer vaccines: the role of tumor burden in tipping the scale toward vaccine efficacy Journal of Clinical Oncology 2005 23 30 7397 7398
19. Seif A. E., Barrett D. M., Milone M., Brown V. I., Grupp S. A., Reid G. S. D., Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses Blood 2009 114 12 2459 2466
20. Buckwalter M. R., Srivastava P. K., It is the antigen(s), stupid and other lessons from over a decade of vaccitherapy of human cancer Seminars in Immunology 2008 20 5 296 300
21. Burnet M., Cancer; a biological approach. I. The processes of control British Medical Journal 1957 1 5022 779 786
22. Matzinger P., The danger model: a renewed sense of self Science 2002 296 5566 301 305
23. Martin S. E., Martin W. J., Anti tumor antibodies in normal mouse sera International Journal of Cancer 1975 15 4 658 664
24. Takahashi T., Johnson T. D., Nishinaka Y., Morton D. L., Irie R. F., IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients Journal of Investigative Dermatology 1999 112 2 205 209
25. Dair'Olio F., Protein glycosylation in cancer biology: an overview Journal of Clinical Pathology 1996 49 3 M126 M135
26. Galili U., The -gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy Immunology and Cell Biology 2005 83 6 674 686
27. Luo P., Canziani G., Cunto-Amesty G., Kieber-Emmons T., A molecular basis for functional peptide mimicry of a carbohydrate antigen Journal of Biological Chemistry 2000 275 21 16146 16154
28. Cunto-Amesty G., Dam T. K., Luo P., Monzavi-Karbassi B., Brewer C. F., Van Cott T. C., Kieber-Emmons T., Directing the immune response to carbohydrate antigens Journal of Biological Chemistry 2001 276 32 30490 30498
29. Monzavi-Karbassi B., Cunto-Amesty G., Luo P., Kieber-Emmons T., Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery Trends in Biotechnology 2002 20 5 207 214
30. Apostolopoulos V., Sandrin M. S., McKenzie I. F. C., Carbohydrate/peptide mimics: effect on MUC1 cancer immunotherapy Journal of Molecular Medicine 1999 77 5 427 436
31. Pashov A., Monzavi-Karbassi B., Chow M., Cannon M., Kieber-Emmons T., Immune surveillance as a rationale for immunotherapy? Human Vaccines 2007 3 5 224 228
32. Vujanovic L., Butterfield L. H., Melanoma cancer vaccines and anti-tumor T cell responses Journal of Cellular Biochemistry 2007 102 2 301 310
33. van Vliet S. J., Garca-Vallejo J. J., Van Kooyk Y., Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses Immunology and Cell Biology 2008 86 7 580 587
34. Vollmers H. P., Brndlein S., Tumors: too sweet to remember? Molecular Cancer 2007 6, article 78
35. Buzs E. I., Gyrgy B., Pszti M., Jelinek I., Falus A., Gabius H.-J., Carbohydrate recognition systems in autoimmunity Autoimmunity 2006 39 8 691 704
36. Galili U., Immune response, accomodation, and tolerance to transplantation carbohydrate antigens Transplantation 2004 78 8 1093 1098
37. Weintraub A., Immunology of bacterial polysaccharide antigens Carbohydrate Research 2003 338 23 2539 2547
38. 'T Hart B. A., van Kooyk Y., Yin-Yang regulation of autoimmunity by DCs Trends in Immunology 2004 25 7 353 359
39. Ravindranath M. H., Muthugounder S., Hannah M. R., Morton D. L., Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy Annals of the New York Academy of Sciences 2007 1107 212 222
40. Cobb B. A., Kasper D. L., Coming of age: carbohydrates and immunity European Journal of Immunology 2005 35 2 352 356
41. Wang H., Clarke S. H., Regulation of B-cell development by antibody specificity Current Opinion in Immunology 2004 16 2 246 250
42. Carey J. B., Moffatt-Blue C. S., Watson L. C., Gavin A. L., Feeney A. J., Repertoire-based selection into the marginal zone compartment during B cell development Journal of Experimental Medicine 2008 205 9 2043 2052
43. Zhao X.-J., Cheung N.-K. V., GD2 oligosaccharide: target for cytotoxic T lymphocytes Journal of Experimental Medicine 1995 182 1 67 74
44. Dhodapkar M. V., Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges Frontiers in Bioscience 2009 14 796 807
45. Cobb B. A., Wang Q., Tzianabos A. O., Kasper D. L., Polysaccharide processing and presentation by the MHCII pathway Cell 2004 117 5 677 687
46. Vlad A. M., Muller S., Cudic M., Paulsen H., Otvos L. Jr., Hanisch F.-G., Finn O. J., Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells Journal of Experimental Medicine 2002 196 11 1435 1446
47. Evans S. V., Sigurskjold B. W., Jennings H. J., Brisson J.-R., To R., Tse W. C., Altman E., Frosch M., Weisgerber C., Kratzin H. D., Klebert S., Vaesen M., Bitter-Suermann D., Rose D. R., Young N. M., Bundle D. R., Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for -(2→8)-polysialic acid Biochemistry 1995 34 20 6737 6744
48. Forestier C., Moreno E., Mresse S., Phalipon A., Olive D., Sansonetti P., Gorvel J.-P., Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes Infection and Immunity 1999 67 8 4048 4054
49. Tzianabos A. O., Finberg R. W., Wang Y., Chan M., Onderdonk A. B., Jennings H. J., Kasper D. L., T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria Journal of Biological Chemistry 2000 275 10 6733 6740
50. van Kooyk Y., Engering A., Lekkerkerker A. N., Ludwig I. S., Geijtenbeek T. B. H., Pathogens use carbohydrates to escape immunity induced by dendritic cells Current Opinion in Immunology 2004 16 4 488 493
51. Galili U., Rachmilewitz E. A., Peleg A., Flechner I., A unique natural human IgG antibody with anti- -galactosyl specificity Journal of Experimental Medicine 1984 160 5 1519 1531
52. Galili U., Mandrell R. E., Hamadeh R. M., Shohet S. B., Griffiss J. M., Interaction between human natural anti- -galactosyl immunoglobulin G and bacteria of the human flora Infection and Immunity 1988 56 7 1730 1737
53. MCmorrow I. M., Comrack C. A., Sachs D. H., DerSimonian H., Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal( 1,3)Galactose epitope Transplantation 1997 64 3 501 510
54. Barreau N., Blancho G., Boulet C., Martineau A., Vusio P., Liaigre J., Bovin N., Bouhours D., Bouhours J.-F., Natural anti-Gal antibodies constitute 0.2 of intravenous immunoglobulin and are equally retained on a synthetic disaccharide column or on an immobilized natural glycoprotein Transplantation Proceedings 2000 32 5 882 883
55. Sthre M., Slvik U.., Haraldsen G., Fiane A. E., Boretti E., Thorsby E., Platt J. L., Mollnes T. E., Human serum-induced porcine endothelial cell E-selectin expression is associated with IgG3 and IgM anti-Gal antibodies Xenotransplantation 2002 9 5 350 358
56. Dehoux J.-P., de la Parra B., Latinne D., Bazin H., Gianello P., Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft Xenotransplantation 2002 9 5 338 349
57. Jin W. D., Zhou T., Zeng H., Ma L., Verbeek J. S., Yin D., Shen J., Chong A. S., Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc- receptors Journal of Immunology 2008 180 1 261 268
58. Galili U., LaTemple D. C., Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity Immunology Today 1997 18 6 281 285
59. Galili U., Interaction of the natural anti-Gal antibody with -galactosyl epitopes: a major obstacle for xenotransplantation in humans Immunology Today 1993 14 10 480 482
60. Xu Y., Sette A., Sidney J., Gendler S. J., Franco A., Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention Immunology and Cell Biology 2005 83 4 440 448
61. Wolf M. F., Koerner U., Klumpp B., Schumacher K., Characterization of Thomsen-Friedenreich antibody subpopulations from normal human serum Tumor Biology 1987 8 5 264 272
62. Zanetti M., Lenert G., Springer G. F., Idiotypes of pre-existing human anti-carcinoma anti-T and anti-Tn antibodies International Immunology 1993 5 2 113 119
63. Hirohashi S., Clausen H., Yamada T., Shimosato Y., Hakomori S., Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen Proceedings of the National Academy of Sciences of the United States of America 1985 82 20 7039 7043
64. Galili U., Buehler J., Shohet S. B., Macher B. A., The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies Journal of Experimental Medicine 1987 165 3 693 704
65. Smorodin E. P., Kurtenkov O. A., Sergeyev B. L., Kodar K. E., Chuzmarov V. I., Afanasyev V. P., Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients World Journal of Gastroenterology 2008 14 27 4352 4358
66. Kurtenkov O., Klaamas K., Mensdorff-Pouilly S., Miljukhina L., Shljapnikova L., Chumarov V., Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival Acta Oncologica 2007 46 3 316 323 (Pubitemid 46625032)
67. Springer G. F., Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy Journal of Molecular Medicine 1997 75 8 594 602
68. Carbone F. R., Gleeson P. A., Carbohydrates and antigen recognition by T cells Glycobiology 1997 7 6 725 730
69. Janeway C. A. Jr., Cohen B. E., Ben Sasson S. Z., Paul W. E., The specificity of cellular immune responses in guinea pigs. I. T cells specific for 2,4 dinitrophenyl O tyrosyl residues Journal of Experimental Medicine 1975 141 1 42 55
70. Abdel-Motal U. M., Berg L., Rosn A., Bengtsson M., Thorpe C. J., Kihlberg J., Dahmn J., Magnusson G., Karlsson K.-A., Jondal M., Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells European Journal of Immunology 1996 26 3 544 551
71. Michalsson E., Broddefalk J., Engstrm., Kihlberg J., Holmdahl R., Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells European Journal of Immunology 1996 26 8 1906 1910
72. Franco A., CTL-based cancer preventive/therapeutic vaccines for carcinomas: role of tumour-associated carbohydrate antigens Scandinavian Journal of Immunology 2005 61 5 391 397
73. Galli-Stampino L., Meinjohanns E., Frische K., Meldal M., Jensen T., Werdelin O., Mouritsen S., T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity Cancer Research 1997 57 15 3214 3222
74. Glithero A., Tormo J., Haurum J. S., Arsequell G., Valencia G., Edwards J., Springer S., Townsend A., Ya-Lan P., Wormald M., Dwek R. A., Jones E. Y., Elliott T., Crystal structures of two H- 2Db /glycopeptide complexes suggest a molecular basis for CTL cross-reactivity Immunity 1999 10 1 63 74
75. Haurum J. S., Arsequell G., Lellouch A. C., Wong S. Y. C., Dwek R. A., McMichael A. J., Elliott T., Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes Journal of Experimental Medicine 1994 180 2 739 744
76. Haurum J. S., Tan L., Arsequell G., Frodsham P., Lellouch A. C., Moss P. A. H., Dwek R. A., McMichael A. J., Elliott T., Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition European Journal of Immunology 1995 25 12 3270 3276
77. Jensen T., Galli-Stampino L., Mouritsen S., Frische K., Peters S., Meldal M., Werdelin O., T cell recognition of Tn-glycosylated peptide antigens European Journal of Immunology 1996 26 6 1342 1349
78. Jensen T., Hansen P., Galli-Stampino L., Mouritsen S., Frische K., Meinjohanns E., Meldal M., Werdelin O., Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide Journal of Immunology 1997 158 8 3769 3778
79. Kastrup I. B., Stevanovic S., Arsequell G., Valencia G., Zeuthen J., Rammensee H.-G., Elliott T., Haurum J. S., Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo Tissue Antigens 2000 56 2 129 135
80. Speir J. A., Abdel-Motal U. M., Jondal M., Wilson I. A., Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL Immunity 1999 10 1 51 61
81. Stepensky D., Tzehoval E., Vadai E., Eisenbach L., O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma Clinical and Experimental Immunology 2006 143 1 139 149
82. Xu Y., Gendler S. J., Franco A., Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas Journal of Experimental Medicine 2004 199 5 707 716
83. Sandmaier B. M., Oparin D. V., Holmberg L. A., Reddish M. A., MacLean G. D., Longenecker B. M., Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine Journal of Immunotherapy 1999 22 1 54 66
84. Bhm C. M., Mulder M. C., Zennadi R., Notter M., Schmitt-Grff A., Finn O. J., Taylor-Papadimitriou J., Stein H., Clausen H., Riecken E. O., Hanski C., Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation Scandinavian Journal of Immunology 1997 46 1 27 34
85. Franco A., Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions Anti-Cancer Agents in Medicinal Chemistry 2008 8 1 86 91
86. Apostolopoulos V., Osinski C., McKenzie I. F. C., MUC1 cross-reactive Gal (1,3)Gal antibodies in humans switch immune responses from cellular to humoral Nature Medicine 1998 4 3 315 320
87. Apostolopoulos V., Sandrin M. S., McKenzie I. F. C., Mimics and cross reactions of relevance to tumour immunotherapy Vaccine 1999 18 3-4 268 275
88. MacLean G. D., Reddish M. A., Koganty R. R., Longenecker B. M., Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine Journal of Immunotherapy 1996 19 1 59 68
89. Sandrin M. S., Vaughan H. A., Xing P.-X., McKenzie I. F. C., Natural human anti-Gal (1,3)Gal antibodies react with human mucin peptides Glycoconjugate Journal 1997 14 1 97 105
90. Monzavi-Karbassi B., Cunto-Amesty G., Luo P., Lees A., Kieber-Emmons T., Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies Biologicals 2001 29 3-4 249 257
91. Monzavi-Karbassi B., Luo P., Jousheghany F., Torres-Quiones M., Cunto-Amesty G., Artaud C., Kieber-Emmons T., A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response Cancer Research 2004 64 6 2162 2166
92. Monzavi-Karbassi B., Shamloo S., Kieber-Emmons M., Jousheghany F., Luo P., Lin K. Y., Cunto-Amesty G., Weiner D. B., Kieber-Emmons T., Priming characteristics of peptide mimotopes of carbohydrate antigens Vaccine 2003 21 7-8 753 760
93. Cunto-Amesty G., Luo P., Monzavi-Karbassi B., Lees A., Kieber-Emmons T., Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development Vaccine 2001 19 1719 2361 2368
94. Kottke T., Pulido J., Thompson J., Sanchez-Perez L., Chong H., Calderwood S. K., Selby P., Harrington K., Strome S. E., Melcher A., Vile R. G., Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas Cancer Research 2009 69 19 7767 7774
95. Knutson K. L., Disis M. L., Tumor antigen-specific T helper cells in cancer immunity and immunotherapy Cancer Immunology, Immunotherapy 2005 54 8 721 728
96. Hung K., Hayashi R., Lafond-Walker A., Lowenstein C., Pardoll D., Levitsky H., The central role of CD4+ T cells in the antitumor immune response Journal of Experimental Medicine 1998 188 12 2357 2368
97. Wang R.-F., The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity Trends in Immunology 2001 22 5 269 276
98. Livingstone A. M., Wilson E. B., Ontiveros F., Wang J.-C.E., Unravelling the mechanisms of help for CD8+ T cell responses Immunologic Research 2009 45 2-3 209 217
99. Black C. A., Delayed type hypersensitivity: current theories with an historic perspective Dermatology Online Journal 1999 5 1 7
100. Osorio M., Gracia E., Rodrguez E., Saurez G., Arango M. D.C., Noris E., Torriella A., Joan A., Gmez E., Anasagasti L., Gonzlez J. L., Melgares M. D.L.A., Torres I., Gonzlez J., Alonso D., Rengifo E., Carr A., Prez R., Fernndez L. E., Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study Cancer Biology and Therapy 2008 7 4 488 495
101. Kim S. K., Ragupathi G., Cappello S., Kagan E., Livingston P. O., Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates Vaccine 2000 19 4-5 530 537
102. Ravindranath M. H., Bauer P. M., Amiri A. A., Miri S. M., Kelley M. C., Jones R. C., Morton D. L., Cellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens (sialyl Lea, sialyl Lex, GD3 and GM2) better than soluble lysate cancer vaccine Anti-Cancer Drugs 1997 8 3 217 224
103. Puccetti P., Bianchi R., Romani L., Cenci E., Fioretti M. C., Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization International Journal of Cancer 1989 43 2 279 284
104. Kuramoto E., Watanabe N., Iwata D., Yano O., Shimada S., Tokunaga T., Changes of host cell infiltration into Meth A fibrosarcoma tumor during the course of regression induced by injections of a BCG nucleic acid fraction International Journal of Immunopharmacology 1992 14 5 773 782
105. Szczepanik M., Akahira-Azuma M., Bryniarski K., Tsuji R. F., Kawikova I., Ptak W., Kiener C., Campos R. A., Askenase P. W., B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity Journal of Immunology 2003 171 11 6225 6235
106. Tsuji R. F., Szczepanik M., Kawikova I., Paliwal V., Campos R. A., Itakura A., Akahira-Azuma M., Baumgarth N., Herzenberg L. A., Askenase P. W., B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity Journal of Experimental Medicine 2002 196 10 1277 1290
107. Schreiber H., Wu T. H., Nachman J., Rowley D. A., Immunological enhancement of primary tumor development and its prevention Seminars in Cancer Biology 2000 10 5 351 357
108. Vollmers H. P., Brndlein S., The early birds: natural IgM antibodies and immune surveillance Histology and Histopathology 2005 20 3 927 937
109. Dighiero G., Lymberi P., Holmberg D., High frequency of natural autoantibodies in normal newborn mice Journal of Immunology 1985 134 2 765 771
110. Gil J., Alvarez R., Vinuela J. E., Ruiz De Morales J. G., Bustos A., De La Concha E. G., Subiza J. L., Inhibition of in vivo tumor growth by a monoclonal IgM antibody recognizing tumor cell surface carbohydrates Cancer Research 1990 50 22 7301 7306
111. Zhong X., Gao W., Degauque N., Bai C., Lu Y., Kenny J., Oukka M., Strom T. B., Rothstein T. L., Reciprocal generation of Th1/Th17 and Treg cells by B1 and B2 B cells European Journal of Immunology 2007 37 9 2400 2404
112. Croft M., Swain S. L., Analysis of CD4+ T cells that provide contact-dependent bystander help to B cells Journal of Immunology 1992 149 10 3157 3165
113. Monzavi-Karbassi B., Hennings L. J., Artaud C., Liu T., Jousheghany F., Pashov A., Murali R., Hutchins L. F., Kieber-Emmons T., Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma Vaccine 2007 25 16 3022 3031
114. Wondimu A., Zhang T., Kieber-Emmons T., Gimotty P., Sproesser K., Somasundaram R., Ferrone S., Tsao C.-Y., Herlyn D., Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice Cancer Immunology, Immunotherapy 2008 57 7 1079 1089
115. Dai Y. D., Carayanniotis G., Sercarz E., Antigen processing by autoreactive B cells promotes determinant spreading Cellular amp; Molecular Immunology 2005 2 3 169 175
116. Deola S., Panelli M. C., Maric D., Selleri S., Dmitrieva N. I., Voss C. Y., Klein H., Stroncek D., Wang E., Marincola F. M., Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27/CD70 interactions Journal of Immunology 2008 180 3 1362 1372
117. Askenase P. W., Yes T cells, but three different T cells (, and NK T cells), and also B-1 cells mediate contact sensitivity Clinical and Experimental Immunology 2001 125 3 345 350
118. Matsushita T., Yanaba K., Bouaziz J.-D., Fujimoto M., Tedder T. F., Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression Journal of Clinical Investigation 2008 118 10 3420 3430
119. Matsushita T., Immunological memory Advances in Immunology 2008 53 217 265
120. Ochsenbein A. F., Zinkernagel R. M., Natural antibodies and complement link innate and acquired immunity Immunology Today 2000 21 12 624 630
121. Youd M. E., Ferguson A. R., Corley R. B., Synergistic roles of IgM and complement in antigen trapping and follicular localization European Journal of Immunology 2002 32 8 2328 2337
122. Von Boehmer H., Aifantis I., Gounari F., Azogui O., Haughn L., Apostolou I., Jaeckel E., Grassi F., Klein L., Thymic selection revisited: how essential is it? Immunological Reviews 2003 191 62 78
123. Lin M.-L., Zhan Y., Villadangos J. A., Lew A. M., The cell biology of cross-presentation and the role of dendritic cell subsets Immunology and Cell Biology 2008 86 4 353 362
124. Bevan M. J., Cross priming for a secondary cytotoxic respsonse to minor H antigens with H-2 congenic cells which do not cross react in the cytotoxic assay Journal of Experimental Medicine 1976 143 5 1283 1288
125. Heit A., Schmitz F., O'Keeffe M., Staib C., Busch D. H., Wagner H., Huster K. M., Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines Journal of Immunology 2005 174 7 4373 4380
126. Ulmer J. B., Deck R. R., Dewitt C. M., Donnelly J. J., Liu M. A., Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells Immunology 1996 89 1 59 67
127. Boyle J. S., Koniaras C., Lew A. M., Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization International Immunology 1997 9 12 1897 1906
128. Murshid A., Gong J., Calderwood S. K., Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation Expert Review of Vaccines 2008 7 7 1019 1030
129. Shimizu K., Kurosawa Y., Taniguchi M., Steinman R. M., Fujii S.-I., Cross-presentation of glycolipid from tumor cells loaded with -galactosylceramide leads to potent and long-lived T cell-mediated immunity via dendritic cells Journal of Experimental Medicine 2007 204 11 2641 2653
130. Valmori D., Souleimanian N. E., Tosello V., Bhardwaj N., Adams S., O'Neill D., Pavlick A., Escalon J. B., Cruz C. M., Angiulli A., Angiulli F., Mears G., Vogel S. M., Pan L., Jungbluth A. A., Hoffmann E. W., Venhaus R., Ritter G., Old L. J., Ayyoub M., Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming Proceedings of the National Academy of Sciences of the United States of America 2007 104 21 8947 8952
131. Qiu C. H., Miyake Y., Kaise H., Kitamura H., Ohara O., Tanaka M., Novel subset of CD8+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens Journal of Immunology 2009 182 7 4127 4136
132. Harbers S. O., Crocker A., Catalano G., D'Agati V., Jung S., Desai D. D., Clynes R., Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance Journal of Clinical Investigation 2007 117 5 1361 1369
133. Ferguson T. A., Herndon J., Elzey B., Griffith T. S., Schoenberger S., Green D. R., Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness Journal of Immunology 2002 168 11 5589 5595
134. Freigang S., Egger D., Bienz K., Hengartner H., Zinkernagel R. M., Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming Proceedings of the National Academy of Sciences of the United States of America 2003 100 23 13477 13482
135. Zinkernagel R. M., On cross-priming of MHC class I-specific CTL: rule or exception? European Journal of Immunology 2002 32 9 2385 2392
136. Knuth A., Danowski B., Oettgen H. F., Old L. J., T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures Proceedings of the National Academy of Sciences of the United States of America 1984 81 11 3511 3515
137. Kundig T. M., Bachmann M. F., Lefrancois L., Puddington L., Hengartner H., Zinkernagel R. M., Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells Journal of Immunology 1993 150 10 4450 4456
138. Schendel D. J., Gansbacher B., Oberneder R., Kriegmair M., Hofstetter A., Riethmuller G., Segurado O. G., Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines Journal of Immunology 1993 151 8 4209 4220
139. Schnurr M., Galambos P., Scholz C., Then F., Dauer M., Endres S., Eigler A., Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines Cancer Research 2001 61 17 6445 6450
140. Wrtzen P. A., Pedersen L.., Poulsen H. S., Claesson M. H., Specific killing of p53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted p53-specific CTL line International Journal of Cancer 2001 93 6 855 861
141. Zirlik K. M., Zahrieh D., Neuberg D., Gribben J. G., Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide Blood 2006 108 12 3865 3870
142. Wang B., Kuroiwa J. M. Y., He L.-Z., Charalambous A., Keler T., Steinman R. M., The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells Annals of the New York Academy of Sciences 2009 1174 6 17
143. Galili U., Autologous tumor vaccines processed to express -gal epitopes: a practical approach to immunotherapy in cancer Cancer Immunology, Immunotherapy 2004 53 11 935 945
144. Hermans I. F., Ritchie D. S., Yang J., Roberts J. M., Ronchese F., CD 8 + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity Journal of Immunology 2000 164 6 3095 3101
145. Kilpatrick D. C., Animal lectins: a historical introduction and overview Biochimica et Biophysica Acta 2002 1572 2-3 187 197
146. East L., Isacke C. M., The mannose receptor family Biochimica et Biophysica Acta 2002 1572 2-3 364 386
147. Shrimpton R. E., Butler M., Morel A.-S., Eren E., Hue S. S., Ritter M. A., CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self Molecular Immunology 2009 46 6 1229 1239
148. Burgdorf S., Lukacs-Kornek V., Kurts C., The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation Journal of Immunology 2006 176 11 6770 6776
149. Ramakrishna V., Treml J. F., Vitale L., Connolly J. E., O'Neill T., Smith P. A., Jones C. L., He L.-Z., Goldstein J., Wallace P. K., Keler T., Endres M. J., Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules Journal of Immunology 2004 172 5 2845 2852
150. He L.-Z., Crocker A., Lee J., Mendoza-Ramirez J., Wang X.-T., Vitale L. A., O'Neill T., Petromilli C., Zhang H.-F., Lopez J., Rohrer D., Keler T., Clynes R., Antigenic targeting of the human mannose receptor induces tumor immunity Journal of Immunology 2007 178 10 6259 6267
151. Dasgupta S., Navarrete A.-M., Bayry J., Delignat S., Wootla B., Andr S., Christophe O., Nascimbeni M., Jacquemin M., Martinez-Pomares L., Geijtenbeek T. B.H., Moris A., Saint-Remy J.-M., Kazatchkine M. D., Kaveri S. V., Lacroix-Desmazes S., A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes Proceedings of the National Academy of Sciences of the United States of America 2007 104 21 8965 8970
152. Chieppa M., Bianchi G., Doni A., Del Prete A., Sironi M., Laskarin G., Monti P., Piemonti L., Biondi A., Mantovani A., Introna M., Allavena P.,
153. Idoyaga J., Cheong C., Suda K., Suda N., Kim J. Y., Lee H., Chae G. P., Steinman R. M., Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo Journal of Immunology 2008 180 6 3647 3650
154. Singh S. K., Stephani J., Schaefer M., Kalay H., Garca-Vallejo J.J., den Haan J., Saeland E., Sparwasser T., van Kooyk Y., Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation Molecular Immunology 2009 47 2-3 164 174
155. Takahara K., Omatsu Y., Yashima Y., Maeda Y., Tanaka S., Iyoda T., Clusen B., Matsubara K., Letterio J., Steinman R. M., Matsuda Y., Inaba K., Identification and expression of mouse Langerin (CD207) in dendritic cells International Immunology 2002 14 5 433 444
156. van Die I., van Vliet S. J., Nyame A. K., Cummings R. D., Bank C. M. C., Appelmelk B., Geijtenbeek T. B. H., van Kooyk Y., The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x Glycobiology 2003 13 6 471 478
157. Galustian C., Park C. G., Chai W., Kiso M., Bruening S. A., Kang Y.-S., Steinman R. M., Feizi T., High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin International Immunology 2004 16 6 853 866
158. Monzavi-Karbassi B., Luo P., Cunto-Amesty G., Jousheghany F., Pashov A., Weissman D., Kieber-Emmons T., Fucosylated lactosamines participate in adhesion of HIV-1 envelope glycoprotein to dendritic cells Archives of Virology 2004 149 1 75 91
159. Ujita M., Nagayama H., Kanie S., Koike S., Ikeyama Y., Ozaki T., Okumura H., Carbohydrate binding specificity of recombinant human macrophage -glucan receptor dectin-1 Bioscience, Biotechnology and Biochemistry 2009 73 1 237 240
160. Ferwerda G., Meyer-Wentrup F., Kullberg B.-J., Netea M. G., Adema G. J., Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages Cellular Microbiology 2008 10 10 2058 2066
161. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T. L., Oswald-Richter K., Kasprowicz D. J., Kellar K., Pare J., Van Dyke T., Ziegler S., Unutmaz D., Pulendran B., Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance Journal of Clinical Investigation 2006 116 4 916 928
162. Hernanz-Falcn P., Joffre O., Williams D. L., Reis e Sousa C., Internalization of dectin-1 terminates induction of inflammatory responses European Journal of Immunology 2009 39 2 507 513
163. Weck M. M., Appel S., Werth D., Sinzger C., Bringmann A., Grnebach F., Brossart P., HDectin-1 is involved in uptake and cross-presentation of cellular antigens Blood 2008 111 8 4264 4272
164. Sancho D., Mouro-S D., Joffre O. P., Schulz O., Rogers N. C., Pennington D. J., Carlyle J. R., Sousa C. R., Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin Journal of Clinical Investigation 2008 118 6 2098 2110
165. Sancho D., Joffre O. P., Keller A. M., Rogers N. C., Martnez D., Hernanz-Falcn P., Rosewell I., Sousa C. R. E., Identification of a dendritic cell receptor that couples sensing of necrosis to immunity Nature 2009 458 7240 899 903
166. Mahnke K., Qian Y., Knop J., Enk A. H., Induction of CD4+ / CD25+ regulatory T cells by targeting of antigens to immature dendritic cells Blood 2003 101 12 4862 4869
167. Cohn M., A rationalized set of default postulates that permit a coherent description of the immune system amenable to computer modeling Scandinavian Journal of Immunology 2008 68 4 371 380
168. Moore T., Ekworomadu C. O., Eko F. O., MacMillan L., Ramey K., Ananaba G. A., Patrickson J. W., Nagappan P. R., Lyn D., Black C. M., Igietseme J. U., Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens Journal of Infectious Diseases 2003 188 4 617 624
169. Casadevall A., Pirofski L., Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans Current Molecular Medicine 2005 5 4 421 433
170. den Haan J. M. M., Bevan M. J., Constitutive versus activation-dependent cross-presentation of immune complexes by CD8+ and CD8- dendritic cells in vivo Journal of Experimental Medicine 2002 196 6 817 827
171. Dhodapkar K. M., Krasovsky J., Williamson B., Dhodapkar M. V., Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells Journal of Experimental Medicine 2002 195 1 125 133
172. Drrbach A., Baple E., Preece A. F., Charpentier B., Gustafsson K., Virus recognition by specific natural antibodies and complement results in MHC I cross-presentation European Journal of Immunology 2007 37 5 1254 1265
173. van Montfoort N., de Jong J. M. H., Schuurhuis D. H., van der Voort E. I. H., Camps M. G. M., Huizinga T. W. J., Van Kooten C., Daha M. R., Verbeek J. S., Ossendorp F., Toes R. E. M., A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes Journal of Immunology 2007 178 12 7581 7586
174. Rafiq K., Bergtold A., Clynes R., Immune complex-mediated antigen presentation induces tumor immunity Journal of Clinical Investigation 2002 110 1 71 79
175. Liu Y., Gao X., Masuda E., Redecha P. B., Blank M. C., Pricop L., Regulated expression of Fc R in human dendritic cells controls cross-presentation of antigen-antibody complexes Journal of Immunology 2006 177 12 8440 8447
176. Nimmerjahn F., Ravetch J. V., Antibodies, Fc receptors and cancer Current Opinion in Immunology 2007 19 2 239 245
177. Nimmerjahn F., Ravetch J. V., Immunology: divergent immunoglobulin G subclass activity through selective Fc receptor binding Science 2005 310 5753 1510 1512
178. Wierzbicki A., Gil M., Ciesielski M., Fenstermaker R. A., Kaneko Y., Rokita H., Lau J. T., Kozbor D., Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells Journal of Immunology 2008 181 9 6644 6653
179. Ding C., Wang L., Marroquin J., Yan J., Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1 Blood 2008 112 7 2817 2825
180. Jerome K. R., Domenech N., Finn O. J., Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA Journal of Immunology 1993 151 3 1654 1662
181. Taylor-Papadimitriou J., Finn O. J., Biology, biochemistry and immunology of carcinoma-associated mucins Immunology Today 1997 18 3 105 107
182. Denton G., Sekowski M., Price M. R., Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens Cancer Letters 1993 70 3 143 150
183. Yu L.-G., Milton J. D., Fernig D. G., Rhodes J. M., Opposite effects on human colon cancer cell proliferation of two dietary Thomse-Friedenreich antigen-binding lectins Journal of Cellular Physiology 2001 186 2 282 287
184. Irazoqui F. J., Jansson B., Lopez P. H. H., Nores G. A., Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation Journal of Biochemistry 2001 130 1 33 37
185. Apostolopoulos V., Karanikas V., Haurum J. S., McKenzie I. F. C., Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen Journal of Immunology 1997 159 11 5211 5218
186. Hebeis B. J., Klenovsek K., Rohwer P., Ritter U., Schneider A., Mach M., Winkler T. H., Activation of virus-specific memory B cells in the absence of T cell help Journal of Experimental Medicine 2004 199 4 593 602
187. Peters B., Sidney J., Bourne P., Bui H.-H., Buus S., Doh G., Fleri W., Kronenberg M., Kubo R., Lund O., Nemazee D., Ponomarenko J. V., Sathiamurthy M., Schoenberger S., Stewart S., Surko P., Way S., Wilson S., Sette A., The immune epitope database and analysis resource: from vision to blueprint PLoS Biology 2005 3 3, article e91
188. Moutaftsi M., Peters B., Pasquetto V., Tscharke D. C., Sidney J., Bui H.-H., Grey H., Sette A., A consensus epitope prediction approach identifies the breadth of murine TCD8+ -cell responses to vaccinia virus Nature Biotechnology 2006 24 7 817 819
189. Lundegaard C., Lamberth K., Harndahl M., Buus S., Lund O., Nielsen M., NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11 Nucleic Acids Research 2008 36, web server issue W509 W512
190. De Groot A. S., McMurry J., Moise L., Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates Current Opinion in Pharmacology 2008 8 5 620 626
191. De Groot A. S., Moise L., McMurry J. A., Wambre E., Van Overtvelt L., Moingeon P., Scott D. W., Martin W., Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes Blood 2008 112 8 3303 3311
192. Rahbarizadeh F., Rasaee M. J., Forouzandeh M., Allameh A., Sarrami R., Nasiry H., Sadeghizadeh M., The production and characterization of novel heavy-chain antibodies against the tandem repeat region of MUC1 mucin Immunological Investigations 2005 34 4 431 452
193. Croce M. V., Isla-Larrain M. T., Capafons A., Price M. R., Segal-Eiras A., Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women Breast Cancer Research and Treatment 2001 69 1 1 11